[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

United States HER2 Antibodies Market Report 2017

October 2017 | 104 pages | ID: UAB267E04A8PEN
QYResearch

US$ 3,800.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In this report, the United States HER2 Antibodies market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
  • The West
  • Southwest
  • The Middle Atlantic
  • New England
  • The South
  • The Midwest
  • with sales (volume), revenue (value), market share and growth rate of HER2 Antibodies in these regions, from 2012 to 2022 (forecast).
United States HER2 Antibodies market competition by top manufacturers/players, with HER2 Antibodies sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
  • Novartis AG
  • Pfizer, Inc.
  • Genentech Inc. (F. Hoffmann-La Roche Ltd.)
  • Abnova Corporation
  • InvivoGen
  • Celltrion, Inc.
  • Biocon Limited
  • Bio-Techne (Novus Biologicals, LLC)
On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
  • Trastuzumab
  • Lapatinib'
  • Ado-trastuzumab emtansine'
  • Pertuzumab ''
  • Everolimus''
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of HER2 Antibodies for each application, including
  • Application 1
  • Application 2
United States HER2 Antibodies Market Report 2017

1 HER2 ANTIBODIES OVERVIEW

1.1 Product Overview and Scope of HER2 Antibodies
1.2 Classification of HER2 Antibodies by Product Category
  1.2.1 United States HER2 Antibodies Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States HER2 Antibodies Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Trastuzumab
  1.2.4 Lapatinib?
  1.2.5 Ado-trastuzumab emtansine?
  1.2.6 Pertuzumab ??
  1.2.7 Everolimus??
1.3 United States HER2 Antibodies Market by Application/End Users
  1.3.1 United States HER2 Antibodies Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.1 Application
  1.3.2 Application
1.4 United States HER2 Antibodies Market by Region
  1.4.1 United States HER2 Antibodies Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West HER2 Antibodies Status and Prospect (2012-2022)
  1.4.3 Southwest HER2 Antibodies Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic HER2 Antibodies Status and Prospect (2012-2022)
  1.4.5 New England HER2 Antibodies Status and Prospect (2012-2022)
  1.4.6 The South HER2 Antibodies Status and Prospect (2012-2022)
  1.4.7 The Midwest HER2 Antibodies Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of HER2 Antibodies (2012-2022)
  1.5.1 United States HER2 Antibodies Sales and Growth Rate (2012-2022)
  1.5.2 United States HER2 Antibodies Revenue and Growth Rate (2012-2022)

2 UNITED STATES HER2 ANTIBODIES MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States HER2 Antibodies Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States HER2 Antibodies Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States HER2 Antibodies Average Price by Players/Suppliers (2012-2017)
2.4 United States HER2 Antibodies Market Competitive Situation and Trends
  2.4.1 United States HER2 Antibodies Market Concentration Rate
  2.4.2 United States HER2 Antibodies Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers HER2 Antibodies Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES HER2 ANTIBODIES SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States HER2 Antibodies Sales and Market Share by Region (2012-2017)
3.2 United States HER2 Antibodies Revenue and Market Share by Region (2012-2017)
3.3 United States HER2 Antibodies Price by Region (2012-2017)

4 UNITED STATES HER2 ANTIBODIES SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States HER2 Antibodies Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States HER2 Antibodies Revenue and Market Share by Type (2012-2017)
4.3 United States HER2 Antibodies Price by Type (2012-2017)
4.4 United States HER2 Antibodies Sales Growth Rate by Type (2012-2017)

5 UNITED STATES HER2 ANTIBODIES SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States HER2 Antibodies Sales and Market Share by Application (2012-2017)
5.2 United States HER2 Antibodies Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES HER2 ANTIBODIES PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Novartis AG
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 HER2 Antibodies Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Novartis AG HER2 Antibodies Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Pfizer, Inc.
  6.2.2 HER2 Antibodies Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Pfizer, Inc. HER2 Antibodies Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Genentech Inc. (F. Hoffmann-La Roche Ltd.)
  6.3.2 HER2 Antibodies Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Genentech Inc. (F. Hoffmann-La Roche Ltd.) HER2 Antibodies Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Abnova Corporation
  6.4.2 HER2 Antibodies Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Abnova Corporation HER2 Antibodies Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 InvivoGen
  6.5.2 HER2 Antibodies Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 InvivoGen HER2 Antibodies Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Celltrion, Inc.
  6.6.2 HER2 Antibodies Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Celltrion, Inc. HER2 Antibodies Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Biocon Limited
  6.7.2 HER2 Antibodies Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Biocon Limited HER2 Antibodies Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Bio-Techne (Novus Biologicals, LLC)
  6.8.2 HER2 Antibodies Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Bio-Techne (Novus Biologicals, LLC) HER2 Antibodies Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview

7 HER2 ANTIBODIES MANUFACTURING COST ANALYSIS

7.1 HER2 Antibodies Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of HER2 Antibodies

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 HER2 Antibodies Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of HER2 Antibodies Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES HER2 ANTIBODIES MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States HER2 Antibodies Sales Volume, Revenue Forecast (2017-2022)
11.2 United States HER2 Antibodies Sales Volume Forecast by Type (2017-2022)
11.3 United States HER2 Antibodies Sales Volume Forecast by Application (2017-2022)
11.4 United States HER2 Antibodies Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.


LIST OF TABLES AND FIGURES

Figure Product Picture of HER2 Antibodies
Figure United States HER2 Antibodies Market Size (MT) by Type (2012-2022)
Figure United States HER2 Antibodies Sales Volume Market Share by Type (Product Category) in 2016
Figure Trastuzumab Product Picture
Figure Lapatinib? Product Picture
Figure Ado-trastuzumab emtansine? Product Picture
Figure Pertuzumab ?? Product Picture
Figure Everolimus?? Product Picture
Figure United States HER2 Antibodies Market Size (MT) by Application (2012-2022)
Figure United States Sales Market Share of HER2 Antibodies by Application in 2016
Figure United States HER2 Antibodies Market Size (Million USD) by Region (2012-2022)
Figure The West HER2 Antibodies Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest HER2 Antibodies Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic HER2 Antibodies Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England HER2 Antibodies Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US HER2 Antibodies Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest HER2 Antibodies Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States HER2 Antibodies Sales (MT) and Growth Rate (2012-2022)
Figure United States HER2 Antibodies Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States HER2 Antibodies Market Major Players Product Sales Volume (MT) (2012-2017)
Table United States HER2 Antibodies Sales (MT) of Key Players/Suppliers (2012-2017)
Table United States HER2 Antibodies Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States HER2 Antibodies Sales Share by Players/Suppliers
Figure 2017 United States HER2 Antibodies Sales Share by Players/Suppliers
Figure United States HER2 Antibodies Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States HER2 Antibodies Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States HER2 Antibodies Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States HER2 Antibodies Revenue Share by Players/Suppliers
Figure 2017 United States HER2 Antibodies Revenue Share by Players/Suppliers
Table United States Market HER2 Antibodies Average Price (USD/Kg) of Key Players/Suppliers (2012-2017)
Figure United States Market HER2 Antibodies Average Price (USD/Kg) of Key Players/Suppliers in 2016
Figure United States HER2 Antibodies Market Share of Top 3 Players/Suppliers
Figure United States HER2 Antibodies Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers HER2 Antibodies Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers HER2 Antibodies Product Category
Table United States HER2 Antibodies Sales (MT) by Region (2012-2017)
Table United States HER2 Antibodies Sales Share by Region (2012-2017)
Figure United States HER2 Antibodies Sales Share by Region (2012-2017)
Figure United States HER2 Antibodies Sales Market Share by Region in 2016
Table United States HER2 Antibodies Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States HER2 Antibodies Revenue Share by Region (2012-2017)
Figure United States HER2 Antibodies Revenue Market Share by Region (2012-2017)
Figure United States HER2 Antibodies Revenue Market Share by Region in 2016
Table United States HER2 Antibodies Price (USD/Kg) by Region (2012-2017)
Table United States HER2 Antibodies Sales (MT) by Type (2012-2017)
Table United States HER2 Antibodies Sales Share by Type (2012-2017)
Figure United States HER2 Antibodies Sales Share by Type (2012-2017)
Figure United States HER2 Antibodies Sales Market Share by Type in 2016
Table United States HER2 Antibodies Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States HER2 Antibodies Revenue Share by Type (2012-2017)
Figure Revenue Market Share of HER2 Antibodies by Type (2012-2017)
Figure Revenue Market Share of HER2 Antibodies by Type in 2016
Table United States HER2 Antibodies Price (USD/Kg) by Types (2012-2017)
Figure United States HER2 Antibodies Sales Growth Rate by Type (2012-2017)
Table United States HER2 Antibodies Sales (MT) by Application (2012-2017)
Table United States HER2 Antibodies Sales Market Share by Application (2012-2017)
Figure United States HER2 Antibodies Sales Market Share by Application (2012-2017)
Figure United States HER2 Antibodies Sales Market Share by Application in 2016
Table United States HER2 Antibodies Sales Growth Rate by Application (2012-2017)
Figure United States HER2 Antibodies Sales Growth Rate by Application (2012-2017)
Table Novartis AG Basic Information List
Table Novartis AG HER2 Antibodies Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Novartis AG HER2 Antibodies Sales Growth Rate (2012-2017)
Figure Novartis AG HER2 Antibodies Sales Market Share in United States (2012-2017)
Figure Novartis AG HER2 Antibodies Revenue Market Share in United States (2012-2017)
Table Pfizer, Inc. Basic Information List
Table Pfizer, Inc. HER2 Antibodies Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Pfizer, Inc. HER2 Antibodies Sales Growth Rate (2012-2017)
Figure Pfizer, Inc. HER2 Antibodies Sales Market Share in United States (2012-2017)
Figure Pfizer, Inc. HER2 Antibodies Revenue Market Share in United States (2012-2017)
Table Genentech Inc. (F. Hoffmann-La Roche Ltd.) Basic Information List
Table Genentech Inc. (F. Hoffmann-La Roche Ltd.) HER2 Antibodies Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Genentech Inc. (F. Hoffmann-La Roche Ltd.) HER2 Antibodies Sales Growth Rate (2012-2017)
Figure Genentech Inc. (F. Hoffmann-La Roche Ltd.) HER2 Antibodies Sales Market Share in United States (2012-2017)
Figure Genentech Inc. (F. Hoffmann-La Roche Ltd.) HER2 Antibodies Revenue Market Share in United States (2012-2017)
Table Abnova Corporation Basic Information List
Table Abnova Corporation HER2 Antibodies Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Abnova Corporation HER2 Antibodies Sales Growth Rate (2012-2017)
Figure Abnova Corporation HER2 Antibodies Sales Market Share in United States (2012-2017)
Figure Abnova Corporation HER2 Antibodies Revenue Market Share in United States (2012-2017)
Table InvivoGen Basic Information List
Table InvivoGen HER2 Antibodies Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure InvivoGen HER2 Antibodies Sales Growth Rate (2012-2017)
Figure InvivoGen HER2 Antibodies Sales Market Share in United States (2012-2017)
Figure InvivoGen HER2 Antibodies Revenue Market Share in United States (2012-2017)
Table Celltrion, Inc. Basic Information List
Table Celltrion, Inc. HER2 Antibodies Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Celltrion, Inc. HER2 Antibodies Sales Growth Rate (2012-2017)
Figure Celltrion, Inc. HER2 Antibodies Sales Market Share in United States (2012-2017)
Figure Celltrion, Inc. HER2 Antibodies Revenue Market Share in United States (2012-2017)
Table Biocon Limited Basic Information List
Table Biocon Limited HER2 Antibodies Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Biocon Limited HER2 Antibodies Sales Growth Rate (2012-2017)
Figure Biocon Limited HER2 Antibodies Sales Market Share in United States (2012-2017)
Figure Biocon Limited HER2 Antibodies Revenue Market Share in United States (2012-2017)
Table Bio-Techne (Novus Biologicals, LLC) Basic Information List
Table Bio-Techne (Novus Biologicals, LLC) HER2 Antibodies Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Bio-Techne (Novus Biologicals, LLC) HER2 Antibodies Sales Growth Rate (2012-2017)
Figure Bio-Techne (Novus Biologicals, LLC) HER2 Antibodies Sales Market Share in United States (2012-2017)
Figure Bio-Techne (Novus Biologicals, LLC) HER2 Antibodies Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of HER2 Antibodies
Figure Manufacturing Process Analysis of HER2 Antibodies
Figure HER2 Antibodies Industrial Chain Analysis
Table Raw Materials Sources of HER2 Antibodies Major Players/Suppliers in 2016
Table Major Buyers of HER2 Antibodies
Table Distributors/Traders List
Figure United States HER2 Antibodies Sales Volume (MT) and Growth Rate Forecast (2017-2022)
Figure United States HER2 Antibodies Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States HER2 Antibodies Price (USD/Kg) Trend Forecast (2017-2022)
Table United States HER2 Antibodies Sales Volume (MT) Forecast by Type (2017-2022)
Figure United States HER2 Antibodies Sales Volume (MT) Forecast by Type (2017-2022)
Figure United States HER2 Antibodies Sales Volume (MT) Forecast by Type in 2022
Table United States HER2 Antibodies Sales Volume (MT) Forecast by Application (2017-2022)
Figure United States HER2 Antibodies Sales Volume (MT) Forecast by Application (2017-2022)
Figure United States HER2 Antibodies Sales Volume (MT) Forecast by Application in 2022
Table United States HER2 Antibodies Sales Volume (MT) Forecast by Region (2017-2022)
Table United States HER2 Antibodies Sales Volume Share Forecast by Region (2017-2022)
Figure United States HER2 Antibodies Sales Volume Share Forecast by Region (2017-2022)
Figure United States HER2 Antibodies Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

More Publications

Need Help?

Ask a Question

Market Reports

All Categories